A National Confidential Enquiry into Patient Outcome and Death recently found delays in the processing of care in over a third of patients with pulmonary embolism (PE). With over 10% of deaths in hospital related to PE, how can the NHS further improve prevention, diagnosis and treatment of this potentially deadly condition?
Venous thromboembolism (VTE)
Venous thromboembolism (VTE) is a condition in which a blood clot forms most often in the deep veins of the leg, groin or arm (known as deep vein thrombosis [DVT]) and travels in the
As the global population ages, the medical, societal and economic costs related to pulmonary embolisms will grow circulation, lodging in the lungs (known as pulmonary embolism [PE]). Together, DVT and PE are known as VTE – a potentially fatal deadly medical condition.
The latest figures from NHS England and the World Health Organization (WHO) suggest that significant progress has been achieved in tackling morbidity and mortality associated with venous thromboembolism (VTE). In particular, the UK requirement for all hospitalised patients to have a VTE risk assessment at admission, has led to a significant improvement in assessment and prevention.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
